UCB
The Non-Clinical Formulation Development Lead shapes formulation strategies for small molecules, peptides, and synthetic medicines from discovery through non-clinical development. This role provides scientific direction for formulation screening and regulated studies while connecting scientific teams to orient future clinical formulations. The position involves translating complex data into clear development decisions and regulatory documentation to foster innovation and improve scientific quality.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
UCB didn’t post a salary, so this is our estimate from similar listings.
Scientist II, Drug Product Design & Development
AbbVie
Associate Director, Biopharmaceutics
AbbVie
Advanced Research Scientist
Novo Nordisk A/S
Preformulation Pharmaceutical Scientist
Cytokinetics
Research Advisor, Drug Product - SMDD
Eli Lilly and Company
SCIENTIST, FORMULATION AND DP DEVELOPMENT
Sutro Biopharma